Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07288333
PHASE2

Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia

Sponsor: Neurocrine Biosciences

View on ClinicalTrials.gov

Summary

The primary objective for this study is to evaluate the efficacy of NBI-1117570 compared with placebo on improving behavioral and psychological symptoms of schizophrenia in adults who warrant inpatient hospitalization.

Official title: A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-1117570 in Adults With Schizophrenia Who Warrant Inpatient Hospitalization

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

120

Start Date

2026-03

Completion Date

2027-08

Last Updated

2026-03-03

Healthy Volunteers

No

Conditions

Interventions

DRUG

NBI-1117570

Oral administration

DRUG

Placebo

Oral administration